Extracellular fluid (ECF) is associated with blood pressure, but reports on the status of the ECF volume in hypertension have been inconsistent. The aim of this study was to assess the ECF volume status in hypertensives with regard to body size in a large cohort. We performed a single-center case-control observation study for patients who visited the outpatient hypertension clinic and health examination center. For all eligible participants, we examined the body composition, including fluid compartments, using a noninvasive bioimpedance analysis. Of 2934 subjects (women 1365, 57.5 ± 12.2 years), 1166 subjects were normotensive and 1768 subjects were hypertensive. The ECF volume was larger in female hypertensives than in normotensives but was not different between the male groups. However, the relative ECF, defined as the ratio of ECF to body mass index (BMI), was significantly lower in hypertensives of both genders (Po0.001). ECF revealed an almost twofold stronger correlation with the fat-free mass (FFM) (r ¼ 0.9 in both genders) than with the fat mass, BMI or waist circumference and a negative correlation with age. In contrast, the relative ECF was positively correlated only with the FFM and inversely correlated with the other factors. In the multivariate logistic regression analysis, an increase of 1 s.d. in the relative ECF decreased the relative risk of hypertension by 30% in women (odds ratio (OR), 0.70; 95% confidence interval (CI), 0.56-0.87) and by 28% in men (OR, 0.72; 95% CI, 0.60-0.86), but the ECF was not independently associated with hypertension in either gender. The ECF with regard to the body size was contracted in hypertensives and independently associated with hypertension, whereas the absolute ECF volume was not. 
INTRODUCTION
Hypertension affected more than a quarter of the world adult population in 2000, and its prevalence is growing, as it is predicted to increase up to 29%-to 1.56 billion people-by 2025. 1 Therefore, the global initiative is increasingly stressed in favor of the more precise management of hypertension. However, 95% of hypertensive subjects are classified as having primary hypertension, indicating that there is no clearly known origin that might explain the initiation of hypertension.
In general, the elevation of extracellular fluid (ECF) increases the preload, which eventually contributes to the generation of hypertension. 2 However, the volume of ECF in hypertension has been reported to be diverse (expanded, normal or reduced), and most results were from small-sized studies. [3] [4] [5] [6] [7] [8] [9] [10] Moreover, those studies mostly evaluated only the absolute ECF amount, although ECF is largely dependent on the size and composition of the body. 11 As the hydration of fat mass (FM) differs markedly from that of the fat-free mass (FFM), the recognition of these differences would be important for a better understanding of the relationship of ECF to hypertension. failure (kidney, heart and liver) or other major disease; (4) clinically detectable fluid retention (peripheral edema, neck vein distension or lymphedema); (5) use of drugs such as diuretics, glucocorticoids, thiazolidinedione, anorexigens, antidepressants and neuroleptics; and (6) pregnancy. Finally, the 2934 eligible subjects for this study included 1768 patients with primary hypertension and 1166 normotensive subjects. All of the subjects were provided written informed consent, and the local Institutional Review Board, in accordance with the Declaration of Helsinki of the World Medical Association, approved the study protocol.
Clinical measurements
The medical history and physical characteristics were obtained by the physicians, and trained research nurses measured the anthropometric characteristics. After at least 10 min of rest, the sitting systolic and diastolic blood pressure (BP) (first and fifth Korotkoff sounds) were recorded twice on a 2-min basis at the office by the research nurse using a random zero mercury sphygmomanometer fitted with an appropriate cuff size. The BP records were averaged for use in the analysis. All blood samples were obtained in the morning in a fasting state. The following clinical and demographic parameters were recorded as follows: age, sex, hypertension (hypertension treated with antihypertensive medications or two or more BP recordings at the office 4140/90 mm Hg), diabetes mellitus (diabetes treated with diet, medications or both or a fasting serum glucose of 4 126 mg dl À1 ) and dyslipidemia (treated hypercholesterolemia or a fasting serum total cholesterol X240 mg dl À1 , triglycerides X200 mg dl À1 , high-density lipoprotein cholesterol o40 mg dl À1 or low-density lipoprotein cholesterol X160 mg dl À1 ). With regard to smoking status, current smokers were defined as actively smoking within the past 12 months. The mean frequency of alcohol consumption was collapsed into a dichotomous variable, o1 or X1 per week. The body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters. Obesity was defined as a BMI of at least 25 kg m À2 using the World Health Organization Asia-Pacific guidelines. 26 
BIA measurements
The body composition and volume of the fluid compartments were obtained by segmental bioelectrical impedance using eight tactile electrodes, according to the manufacturer's instructions (InBody 3.0; Biospace, Seoul, Korea). The subjects were examined in the morning after overnight fasting (X8 h) and emptying their bladder at room temperature. After at least 5 min of rest, the participants wiped the bottom of their feet with a proprietary electrolyte tissue before standing on the electrodes embedded in the scale platform and stood on the platform with electrodes attached to their hands and feet. Thus, a pair of electrodes was attached to the surface of each hand and foot at the thumb, palm, fingers, ball of the foot and heel. These electrodes were connected to current and voltage terminals from an impedance meter via electronic on-off switches, which were regulated by a microprocessor. The participants were instructed to stand upright, grasp the handles of the analyzer, abduct his or her arms and then remain still during the assessment. The frequencies used by the InBody 3.0 analyzer were 5, 50, 250 and 500 kHz. The segmental impedance of the right arm, left arm, trunk, right leg and left leg were measured at each frequency. Low-level frequencies (for example, 1-50 kHz) rely on the conductive properties of the ECF, whereas at the high-level frequencies (for example, 250 kHz), the conductive properties of both intracellular and extracellular water are instrumental. FFM and FM can be calculated from multiple frequency bioimpedance analysis following the application of previously determined constants that represent the contribution of water to FFM. The chemical composition of FFM is assumed to be relatively constant, with a density of 1.1 kg m À3 at 37 1C and a water content of 73%. 27 Thus, the FFM was calculated by multiplying the values for the water volumes of each segment by 1.37.
Statistical analysis
All continuous variables used were normally distributed and expressed as the mean ± s.d. Differences between groups were examined using Student's t-test. Discrete variables were presented as the total number (percentage) and compared using the w 2 -test. Pearson's correlation coefficients were calculated to evaluate the relationships among the numeric study variables. In addition, the ratio of ECF to BMI was categorized into quartiles, and intergroup differences were tested using an analysis of variance or the w 2 -test if appropriately applicable. The associations between ECF or the ratio of ECF to BMI and hypertension were assessed after the standardization of ECF and the ratio of ECF to BMI to a mean of 0 and a s.d. of 1 using multivariate logistic regression analysis. All statistical results were based on two-sided tests, and a P-value o0.05 was considered statistically significant. The data were analyzed using SPSS (Statistical Package for the Social Sciences) for Windows (version 12.0; SPSS, Chicago, IL, USA).
RESULTS
The clinical and anthropometric characteristics of the subjects are shown in Table 1 . The hypertensive subjects appeared to be older in age and to have higher waist circumference, BMI and FM in both genders. They were also more concerned about a higher frequency of obesity, diabetes, dyslipidemia and medication use. No significant differences in the prevalence of current smokers, frequency of alcohol consumption, levels of hematocrit, intracellular fluid, ECF and FFM were found in the comparisons between the groups in men. However, the prevalence of current smokers and the levels of hematocrit, ECF and FFM were higher in the female hypertensives than in the normotensives. The ratio of ECF to BMI was significantly lower in the hypertensives than in the normotensives for both women (38.1±4.9 vs. 39.8±5.4 ( Â 10 À2 l/(kg m À2 )), Po0.001) and men (50.8±6.0 vs. 52.5±6.2 ( Â 10 À2 l/(kg m À2 )), Po0.001). Table 2 displays Pearson's correlation analysis according to gender, representing the relationships among ECF, BMI, the ratio of ECF to BMI and the study variables. The ECF measurements were significantly associated with FM, FFM, BMI and waist circumference (Po0.001 for all) positively and with age negatively (Po0.001) in both genders. In particular, because the correlation coefficient for FFM was B0.9, it was nearly twice as strongly correlated with FFM compared with FM, BMI or waist circumference. The BMI was more strongly correlated with FM and waist circumference than with FFM. The ratio of ECF to BMI showed a significant negative correlation with age, FM, BMI and waist circumference and a significant positive correlation with FFM in both genders.
The cohort was gender specifically divided into quartiles on the basis of the ratio of ECF to BMI. As the ratio of ECF to BMI decreased, there were increases in age and BP and higher prevalences of obesity, hypertension, diabetes and dyslipidemia (Table 3) .
In an age-adjusted model, hypertension was positively associated with ECF and was significantly inversely associated with the ratio of ECF to BMI in both genders (Table 4) . However, the association of ECF did not remain significant after further adjustment for BMI and other variables, whereas the association of the ratio of ECF to BMI remained significant after the multivariable adjustment. As the ratio of ECF to BMI increased by 1 s.d., the odds ratio (OR) of hypertension was 0.70 (95% confidence interval (CI), 0.56-0.87; Po0.001) in women and 0.72 (95% CI, 0.60-0.86; Po0.001) in men.
Concerning the 2188 subjects who were untreated with antihypertensive agents, there was a significant inverse correlation of the ratio of ECF to BMI with BP (r ¼ À0.132 for systolic BP, r ¼ À0.125 for diastolic BP in women and r ¼ À0.142 for systolic BP, r ¼ À0.197 for diastolic BP in men, Po0.001 for all).
DISCUSSION
The major findings in the present study enable us to identify the importance of the relative ECF, defined as the ratio of ECF to BMI, in hypertension. The relative ECF significantly decreased in hypertensives compared with that in normotensives and showed an independent inverse relationship with hypertension in the multivariate analysis.
Although ECF itself was also significantly associated with hypertension in an age-adjusted model, the association was no longer significant after further adjustment for BMI. This finding suggested that the association of ECF with hypertension was largely affected by BMI, which had a moderate correlation with ECF and is one of the strongest risk factors for hypertension. Therefore, ECF per se seemed not to be independently associated with hypertension in this study.
The absolute value of ECF is not legitimately predictive of the physiological standard because it is influenced by body size and composition. 11 However, ECF expansion could elevate the hydrostatic pressure in the artery and hence increase BP. This relationship could hold, at least in the short-term, such as in large-volume intravenous fluid resuscitation in a shock state. The relationship between ECF expansion and hypertension is also widely believed to depend on the development of hypervolemia, increased cardiac output and the subsequent rise in the total peripheral resistance reducing volume expansion and normalizing systemic flow while maintaining a high BP. 6 Although this sequence of events has been demonstrated in some human and experimental forms of hypertension, but not in all, it is considered as one of the mechanisms of obesity-induced hypertension. 28 If the body weight gain is mainly from FM (14% water content per unit weight), 29 there should be a smaller ECF expansion compared with that from FFM (70-80% water content per unit weight). 30 However, the BMI increase was predominantly related to FM rather than to FFM expansion during adulthood, similar to our result (Table 2) . Hence, the relative ECF adjusted for body size inevitably declines as the BMI increases, in contrast to the absolute ECF volume. In the healthy average 70 kg adult human, the total body water is B60% of the body weight or B42 l. 11 This percentage can change, depending on age, gender and degree of adiposity. As a person grows older or becomes fatter, the percentage of total body weight, that is, fluid gradually decreases. 11 We could hypothesize that a decrease in the relative ECF compared with the physiological fluid balance might lead to the compensatory activation of the renin-angiotensinaldosterone system (RAAS), thereby contributing, at least in part, to the development of hypertension. This effect could be one of the reasons why obese people have shown a higher prevalence of hypertension in the general population 2 and might account for the phenomena found in obesity-induced hypertension, such as impaired natriuresis and enhanced circulating RAAS activation despite the remarkable absolute volume expansion and sodium retention. 28 Moreover, renin, angiotensin II, angiotensinogen and angiotensinogen II receptors are found in abundance in adipose mass, suggesting that a local tissue RAAS occurs at the adipocyte level, 31 possibly in response to the absence of fluid around this region. In the present study, as the level of the relative ECF decreased, there were higher proportions of obesity and hypertension (Table 3 ). Supporting data indicating that a decrease in the BP was closely related to a reduction in the abdominal FM 32 and that weight reduction caused the elevation of ECF have been reported. 4, 33 Even a modest reduction in weight can lead to a meaningful reduction in RAAS activity in plasma and adipose tissue. 34 If the RAAS was involved in the relationship between the relative ECF and hypertension, the relationship could be affected by RAAS blockers. However, a further adjustment of the multiple logistic regression analysis with respect to the use of RAAS blockers did not significantly change the results in Table 4 (data not shown). This study was not prospectively designed to reveal the mechanism responsible for the relationship between the relative ECF and hypertension, and the dose and type of RAAS blockers used in the study varied. In addition, the RAAS blocker dose required to lower the BP might not be sufficient to affect the local RAAS. Although the relative ECF can reflect both body size and composition, including adiposity, and thus enable the critical characterization of the water balance in the body; few studies investigating the association of the relative ECF with primary hypertension exist. Raison et al. 4 reported that the ECF volume increased in both obese and non-obese hypertensives when expressed in milliliters or milliliters per unit of height but decreased when expressed in milliliters per kilogram in obese hypertensives (n ¼ 16) but not in non-obese hypertensives (n ¼ 16) compared with control subjects (n ¼ 18). Tarazi et al. 35 also reported similar results. Compared with normotensives, the plasma volume was significantly contracted when expressed per unit height or weight in hypertensive men with a diastolic pressure over 105 mm Hg in their study. However, the previous studies included only a small number of subjects, and ECF was separately divided by the body height or weight; therefore, it could not provide definite insight into the association of the relative ECF with hypertension.
The present study also has several aspects to be discussed. First, due to the nature of a cross-sectional study, we are limited to inferring the absolute causal relationship. Whether these body fluid changes represent the cause or effect of the BP rise is not known. Second, many hypertensive patients were treated with antihypertensive agents. Although we excluded the patients treated with diuretics and other potential agents, that can influence the volume status, the ECF volume might be affected by other drugs. Third, the gold standard for the measurement of water spaces is the isotopic dilution of labeled water or bromide. 13, 22 However, these procedures are invasive because they require blood samples and are expensive due to dosage by mass spectrometry. Therefore, the implementation of these measurements for a large number of subjects is very difficult. These factors also explain why there have only been small-sized clinical studies with potential bias or experimental animal studies and may account for the many conflicting results about the volume status in uncomplicated hypertension. However, we could perform a larger human study using BIA, which is noninvasive, easy, inexpensive, validated and reproducible, for the estimation of body fluid compartments. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] This is the largest-scale human study so far evaluating the relationship between hypertension and fluid compartments. In particular, we adopted the concept of relative ECF using BMI as a reference index. The relative ECF volume with regard to body size was reduced in hypertensive patients and independently inversely associated with hypertension, whereas the absolute ECF volume was not. Although this study did not reveal the causal relationship between ECF or relative ECF and hypertension, these findings could provide new insights into understanding the pathophysiology of primary hypertension.
